Gut Flora Metabolite Reduction After Dietary Intervention (GRADY) (GRADY)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02016430|
Recruitment Status : Recruiting
First Posted : December 20, 2013
Last Update Posted : July 24, 2019
|Condition or disease||Intervention/treatment||Phase|
|Dietary Modification Cardiovascular Risk Factor||Behavioral: MeLT Dietary intervention Behavioral: TLC Dietary intervention Behavioral: MeLT dietary intervention with TMAO||Not Applicable|
This is a pilot human study to characterize the relationship between gut flora-associated TMAO generation and dietary intervention. The investigators hypothesize that tailored dietary interventions may help to reduce the ability for gut flora to generate TMAO in individuals with elevated TMAO levels. Specific aims include:
- To investigate the proportion of subjects with persistently elevated circulating TMAO levels.
- To compare the amount of TMAO generated from gut flora using stable-isotope-labelled choline, carnitine, and betaine in subjects with elevated versus normal circulating TMAO levels.
- To evaluate the effect of dietary interventions on the amount of TMAO generated from gut flora using stable-isotope-labelled choline, carnitine, and betaine in subjects with elevated circulating TMAO levels.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||90 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)|
|Study Start Date :||December 2013|
|Estimated Primary Completion Date :||December 2020|
|Estimated Study Completion Date :||December 2020|
Experimental: MeLT Dietary intervention
Mediterranean Low-TMAO (MeLT) diet
Behavioral: MeLT Dietary intervention
Mediterranean diet containing food with low TMAO content.
Experimental: TLC Dietary intervention
Therapeutic Lifestyle Changes (TLC) diet
Behavioral: TLC Dietary intervention
Standard American Heart Association (AHA) recommendations for dietary counseling
Experimental: MeLT dietary intervention with TMAO
Mediterranean Low TMAO diet with TMAO levels reported
Behavioral: MeLT dietary intervention with TMAO
Mediterranean diet containing food with low TMAO content with TMAO levels provided to the subject for guidance.
- Change in TMAO level [ Time Frame: From baseline to 12 weeks follow-up ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02016430
|Contact: Timothy Engelmanemail@example.com|
|United States, Ohio|
|Cleveland, Ohio, United States, 44195|
|Contact: Timothy Engelman 216-636-6153 firstname.lastname@example.org|
|Principal Investigator: W. H. Wilson Tang, MD|
|Principal Investigator: Stanley L. Hazen, MD|
|Principal Investigator:||W. H. Wilson Tang, MD||The Cleveland Clinic|
|Principal Investigator:||Stanley L. Hazen, MD||The Cleveland Clinic|